Literature DB >> 7701193

Twin studies in narcolepsy.

M Partinen1, C Hublin, J Kaprio, M Koskenvuo, C Guilleminault.   

Abstract

The genetic basis of narcolepsy is reflected by the strong association to human leukocyte antigen DR2 (most specifically to DQB1-0602) and the occasional familial occurrence, with several modes of transmission. At present, 12 monozygotic pairs with at least one affected twin have been reported. Of the three pairs considered concordant, the only well-documented pair is DR2 negative. Of the nine discordant pairs five are well documented, and all of these are DR2 positive. We performed a questionnaire study using a validated measure of narcoleptic symptoms (the Ullanlinna narcolepsy scale or UNS). The questionnaire was sent to 2,191 monozygotic twin pairs included in the Finnish Twin Cohort. In 225 pairs neither of the twins responded. In 1,550 pairs both twins responded, but in the answers of 228 pairs there were some missing data concerning the UNS items. Not a single case suggestive of narcolepsy was found. Narcolepsy in monozygotic twins is very rare. These facts support the hypothesis of a multifactorial etiology with a strong influence of nongenetic environmental factors.

Entities:  

Mesh:

Year:  1994        PMID: 7701193     DOI: 10.1093/sleep/17.suppl_8.s13

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  5 in total

1.  Narcolepsy and influenza vaccination-the inappropriate awakening of immunity.

Authors:  Anoma Nellore; Troy D Randall
Journal:  Ann Transl Med       Date:  2016-10

2.  Higher basophil count decreases narcolepsy risk: a Mendelian randomization study.

Authors:  Ang Li; Hao Li; Junyang Xie; Jianlei Xie; Wenjing Liao; Lijuan Song; Xiaowen Zhang
Journal:  Neurol Sci       Date:  2022-05-12       Impact factor: 3.830

3.  IgH (mu-switch and gamma-1) region restriction fragment length polymorphism in human narcolepsy.

Authors:  S M Singh; C F George; R N Ott; C Rattazzi; C Guilleminault; W C Dement; E Mignot
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

Review 4.  Narcolepsy and the hypocretin system--where motion meets emotion.

Authors:  Jerome M Siegel; Lisa N Boehmer
Journal:  Nat Clin Pract Neurol       Date:  2006-10

5.  Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity.

Authors:  L N Boehmer; M-F Wu; J John; J M Siegel
Journal:  Exp Neurol       Date:  2004-08       Impact factor: 5.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.